# US 2015/0105340 A1 · Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105340 A1
- Document ID: US20150105340A1
- Status: Published application
- Kind: A1
- Application number: 14/572,664
- Filed: 2014-12-16
- Published: 2015-04-16
- Earliest claimed: 2006-10-12
- Assignees: Sanofi-Topaz, Inc.
- Applicants: Sanofi - Topaz, Inc.
- Inventors: Nicholas Spring; Garry T. Gwozdz
- Web page: https://patentgrep.com/patent/US20150105340A1

## CPC

- A01N 43/90: having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A01N 25/00: Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application {, e.g. seed treatment or sequential application}; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N 25/04: Dispersions, {emulsions, suspoemulsions, suspension concentrates} or gels (foams A01N25/16)
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61P 33/00: Antiparasitic agents
- A61P 33/14: Ectoparasiticides, e.g. scabicides
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An avermectin-based topical formulation is disclosed which is useful for prevention and treatment of head lice (Pediculus humanus capitis). This topical formulation may be formulated as a shampoo-condition which comprises an effective amount of avermectin, solubilizers, suspending agents, preservatives, nonionic surfactants, humectants, a silicone compound, and water. Also disclosed are methods of using the topical formulations disclosed within this specification to treat either a susceptible or treatment-resistant strain of lice, as well as uses in the manufacture of a medicament for treating or preventing a lice infestation from a susceptible or treatment-resistant strain in a human patient.

## Claims

### Claim 1

A topical formulation comprising
about 0.1% to about 2.0% by weight ivermectin,
a solubilizer,
about 20% to 30% by weight olive oil,
one or more one paraben preservatives,
a non-ionic surfactant, and
about 30% to 40% by weight water.

### Claim 2 (depends on 1)

The topical formulation of claim 1, comprising about 0.5% by weight ivermectin.

### Claim 3 (depends on 1)

The topical formulation of claim 1, further comprising shea butter.

### Claim 4 (depends on 1)

The topical formulation of claim 1, wherein said solubilizer comprises polysorbate 80, cetyl acetate, acetylated lanolin alcohol or a combination thereof.

### Claim 5 (depends on 1)

The topical formulation of claim 1, comprising methylparaben, propylparaben, ethylparaben, butylparaben, isobutylparaben, isopropylparaben, or benzylparaben, or their sodium salts thereof, or any combination thereof.

### Claim 6 (depends on 1)

The topical formulation of claim 1, wherein said nonionic surfactant is selected from the group consisting of oleyl alcohol, lanolin alcohol, sorbitan tristerate, bees wax, erucyl alcohol, ricinolyl alcohol, arachidyl alcohol, capryl alcohol, capric alcohol, behenyl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, palmitoleyl alcohol, linoleyl alcohol, elaidyl alcohol, elaidolinoleyl alcohol, linolenyl alcohol, elaidolinolenyl alcohol, glycerine, glyceryl triacetate, sorbitol, xylitol, maltitol, polydextrose, quillaia, lactic acid, urea, and combinations thereof.

### Claim 7 (depends on 1)

The topical formulation of claim 1, comprising oleyl alcohol, lanolin alcohol, acetylated lanolin alcohol, sorbitan tristearate, or a combination thereof.

### Claim 8 (depends on 1)

The topical formulation of claim 1, further comprising a conditioner.

### Claim 9 (depends on 8)

The topical formulation of claim 8, wherein said conditioner is selected from the group consisting of cyclomethicone, dimethicone, hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, polydimethylsiloxanes, and combinations thereof.

### Claim 10 (depends on 1)

The topical formulation of claim 1, formulated as a cream, gel, or pomade.

### Claim 11 (depends on 1)

The topical formulation of claim 1 prepared according to a method comprising:
(a) preparing a first solution by dissolving ivermectin in the solubilizer; and
(b) adding to the first solution a second solution comprising the olive oil, the one or more one paraben preservatives, and the non-ionic surfactant; and
(c) dispersing the oil mixture of (b) in water.

### Claim 12 (depends on 11)

The topical formulation of claim 11, wherein the solubilizer phase comprises polysorbate 80, cetyl acetate, acetylated lanolin alcohol or a combination thereof.

### Claim 13 (depends on 1)

A method of treating a head lice infestation in a human patient comprising topically administering to said patient the topical formulation of claim 1 in one dosage or multiple dosages.

### Claim 14 (depends on 13)

The method of claim 13, wherein said human patient is a child.

### Claim 15 (depends on 13)

The method of claim 13, wherein at least about 60 mL of the topical formulation is applied to said human patient.

### Claim 16 (depends on 13)

The method of claim 13, wherein about 1 mL to about 100 mL of the topical formulation is applied to said human patient.

### Claim 17 (depends on 13)

The method of claim 13, wherein said topical formulation is left on the scalp for about 1 to about 60 minutes.

### Claim 18 (depends on 17)

The method of claim 17, wherein said topical formulation is left on the scalp for about 3 minutes, about 5 minutes, or about 10 minutes

### Claim 19 (depends on 1)

The method of claim 1 wherein the topical formulation is administered as a single dose.

### Claim 20 (depends on 1)

The method of claim 1 wherein the topical formulation is administered as an initial dosage with one or two additional dosages.
